Weinstein R L, Kelch R P, Jenner M R, Kaplan S L, Grumbach M M
J Clin Invest. 1974 Jan;53(1):1-6. doi: 10.1172/JCI107526.
The secretion of androgens and estrogens by normal and abnormal testes was compared by determining the concentrations of dehydroepiandrosterone (DHEA), androstenedione (Delta(4)A), testosterone (T), estrone (E(1)), and 17beta-estradiol (E(2)) in peripheral and spermatic venous plasma samples from 14 normal men and 5 men with unilateral testicular atrophy. Four normal men and one patient with unilateral atrophy of the testis were given human chorionic gonadotropin (HCG) before surgery. Plasma estrogens were determined by radioimmunoassay; plasma androgens were measured by the double-isotope dilution derivative technique. Peripheral concentrations of these steroids before and after HCG were similar in both the normal men and the patients with unilateral testicular atrophy. In normal men, the mean +/-SE spermatic venous concentrations were DHEA, 73.1+/-11.7 ng/ml; Delta(4)A, 30.7+/-7.9 ng/ml; T, 751+/-114 ng/ml; E(1), 306+/-55 pg/ml; and E(2), 1298+/-216 pg/ml. Three of four subjects with unilateral testicular atrophy had greatly diminished spermatic venous levels of androgens and estrogens. HCG treatment increased the testicular secretion of DHEA and T fivefold, Delta(4)A threefold, E(1) sixfold, and E(2) eightfold in normal men. In the single subject with an atrophic testis who received HCG, the spermatic venous concentrations of androgens and estrogens were much less than in normal men similarly treated. We conclude that: (a) E(1) is secreted by the human testis, but testicular secretion of E(1) accounts for less than 5% of E(1) production in normal men; (b) HCG stimulation produces increases in spermatic venous estrogens equal to or greater than the changes in androgens, including testosterone; and (c) strikingly decreased secretion of androgen and estrogen by unilateral atrophic human tests cannot be appreciated by analyses of peripheral steroid concentrations.
通过测定14名正常男性和5名单侧睾丸萎缩男性外周血和精索静脉血浆样本中脱氢表雄酮(DHEA)、雄烯二酮(Δ⁴A)、睾酮(T)、雌酮(E₁)和17β - 雌二醇(E₂)的浓度,比较了正常和异常睾丸雄激素和雌激素的分泌情况。4名正常男性和1名单侧睾丸萎缩患者在手术前接受了人绒毛膜促性腺激素(HCG)治疗。血浆雌激素通过放射免疫测定法测定;血浆雄激素通过双同位素稀释衍生技术测量。正常男性和单侧睾丸萎缩患者在接受HCG前后这些类固醇的外周浓度相似。在正常男性中,精索静脉平均±标准误浓度分别为:DHEA,73.1±11.7 ng/ml;Δ⁴A,30.7±7.9 ng/ml;T,751±114 ng/ml;E₁,306±55 pg/ml;E₂,1298±216 pg/ml。4名单侧睾丸萎缩患者中有3名精索静脉雄激素和雌激素水平大幅降低。HCG治疗使正常男性睾丸DHEA和T分泌增加5倍,Δ⁴A增加3倍,E₁增加6倍,E₂增加8倍。在接受HCG治疗的单侧萎缩睾丸的单一受试者中,精索静脉雄激素和雌激素浓度远低于接受类似治疗的正常男性。我们得出以下结论:(a)人睾丸分泌E₁,但在正常男性中,睾丸分泌的E₁占E₁产生量的不到5%;(b)HCG刺激使精索静脉雌激素增加量等于或大于包括睾酮在内的雄激素变化量;(c)通过分析外周类固醇浓度无法察觉单侧萎缩人睾丸雄激素和雌激素分泌的显著降低。